News Focus
News Focus
icon url

FooBarAndGrill

10/26/23 6:58 AM

#437076 RE: meds4life #437065

Because Roche/Genentech recently reported a couple of flops in the Alz space: Gantenerumab & Crenezumab. However, at the moment, Roche is busy with the Telavant acquisition.